NEW YORK ( TheStreet Ratings) -- TheStreet.com Ratings initiated coverage of 40 exchange-traded funds, or ETFs, that accrued a sufficient track record of risk and performance data by the end of August 2011. 16 of the 40 newly rated exchange-traded funds start out in the 'Buy' range. 11 begin at 'Hold' while 13 earned initial grades in the 'Sell' range. Three of the newly rated funds that opened for business by August of 2010 received our highest possible rating of A+, or Excellent. Of these, the best performer, iShares MSCI Indonesia Investable Market Index Fund ( EIDO - Get Report), returned 24.4% in the last year.
This emerging market fund seeks investment results that correspond generally to the price and yield performance of the MSCI Indonesia Investable Market Index. The index is designed to measure the performance of equity securities in the top 99% by market capitalization of equity securities listed on stock exchanges in Indonesia. The other two funds rated at A+ are both Schwab ETFs holding U.S. government debt instruments. Returning 12.2% in a year, the Schwab US TIPS ETF ( SCHP - Get Report) seeks investment results that track the price and yield performance of the Barclays Capital U.S. Treasury Inflation Protected Securities Index. U.S TIPS are securities issued by the U.S. Treasury that generate principal and interest payments designed to adjust for and help protect against inflation. Schwab Intmdt-Term US Treasury ETF ( SCHR - Get Report) targets investment results that track the price and yield performance of the Barclays Capital U.S. 3-10 Year Treasury Bond Index. The Fund invests in U.S Treasury securities that have a remaining maturity of three to ten years, are rated investment grade, and have $250 million or more of outstanding face value. Returning 7.3% in the last year, this ETF earned the top rating of A+ by avoiding volatility experienced by other funds. The best newly rated equity ETF, MSCI ACWI ex US Health Care Sector Index Fund ( AXHE) gained 16.9% in a year. The fund seeks investment results that correspond generally to the price and yield performance of the MSCI All Country World ex USA Health Care Index. The Underlying Index is designed to measure the combined equity market performance of the health care sector of developed and emerging markets countries excluding the US. Foreign healthcare companies held include Novartis AG ( NVS - Get Report), Astrazeneca PLC ( AZN - Get Report), and GlaxoSmithKline PLC ( GSK - Get Report).